Hunt Anthony (CIK 1606030) reported 44 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-06-12). Recent activity: Buy MASS (14,083 shares), Sell RGEN (9,897 shares), Buy BLFS (8,170 shares), Sell RGEN (2,000 shares), Sell RGEN (1,784 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-12 | 908 Devices Inc. (MASS) | Director | Buy | 14,083 | $0 |
| 2026-03-03 | REPLIGEN CORP (RGEN) | Director | Sell | 9,897 | $1.2M |
| 2026-02-26 | BIOLIFE SOLUTIONS INC (BLFS) | Director | Buy | 8,170 | $0 |
| 2025-12-08 | REPLIGEN CORP (RGEN) | Director | Sell | 2,000 | $0 |
| 2025-11-14 | REPLIGEN CORP (RGEN) | Director | Sell | 1,784 | $269,402 |
| 2025-11-14 | REPLIGEN CORP (RGEN) | Director | Sell | 2,100 | $319,557 |
| 2025-11-14 | REPLIGEN CORP (RGEN) | Director | Sell | 2,923 | $447,628 |
| 2025-11-14 | REPLIGEN CORP (RGEN) | Director | Sell | 2,500 | $385,800 |
| 2025-11-14 | REPLIGEN CORP (RGEN) | Director | Sell | 3,000 | $466,350 |
| 2025-11-14 | REPLIGEN CORP (RGEN) | Director | Sell | 5,737 | $896,234 |
| 2025-11-14 | REPLIGEN CORP (RGEN) | Director | Sell | 1,956 | $307,307 |
| 2025-11-14 | REPLIGEN CORP (RGEN) | Director | Buy | 2,952 | $99,984 |
| 2025-11-13 | REPLIGEN CORP (RGEN) | Director | Buy | 25,000 | $846,750 |
| 2025-11-13 | REPLIGEN CORP (RGEN) | Director | Sell | 3,741 | $579,556 |
| 2025-11-13 | REPLIGEN CORP (RGEN) | Director | Sell | 4,740 | $738,729 |
| 2025-11-13 | REPLIGEN CORP (RGEN) | Director | Sell | 4,959 | $776,827 |
| 2025-11-13 | REPLIGEN CORP (RGEN) | Director | Sell | 11,096 | $1.8M |
| 2025-11-13 | REPLIGEN CORP (RGEN) | Director | Sell | 464 | $73,549 |
| 2025-09-11 | REPLIGEN CORP (RGEN) | Director | Buy | 20,000 | $677,400 |
| 2025-09-11 | REPLIGEN CORP (RGEN) | Director | Sell | 96 | $11,169 |
| 2025-09-11 | REPLIGEN CORP (RGEN) | Director | Sell | 1,108 | $131,099 |
| 2025-09-11 | REPLIGEN CORP (RGEN) | Director | Sell | 3,262 | $390,266 |
| 2025-09-11 | REPLIGEN CORP (RGEN) | Director | Sell | 14,882 | $1.8M |
| 2025-09-11 | REPLIGEN CORP (RGEN) | Director | Sell | 7,584 | $920,849 |
| 2025-09-11 | REPLIGEN CORP (RGEN) | Director | Sell | 2,179 | $266,339 |
Source: SEC Form 4 filings · as of 2026-06-12